Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

The root extract of Untica mairei Levl may help treat benign prostatic hyperplasia.

5-alpha reductase inhibitors like finasteride and dutasteride are effective for treating enlarged prostate and male pattern hair loss.

Retinoids can help treat skin pigmentation disorders by affecting melanin production.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

A specific metabolite, not a receptor protein, triggers the production of certain kidney enzymes, but this process is disrupted in mice with a mutation causing testicular feminization.

Post-Finasteride Syndrome causes lasting sexual, mood, and metabolic issues, needing personalized treatment and better informed consent.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

Compounds from Angelica koreana roots, especially osthenol, could be effective for treating conditions like prostate disease and hair loss.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Topical 5α-reductase inhibitor helps counteract hair loss and stabilize it.

5% topical minoxidil improves hair density and quality in monilethrix patients.

Enzymes involved in Vitamin A metabolism affect hair growth and type in mice.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Certain hormone levels can help diagnose P450 oxidoreductase deficiency.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

CYP154C7 enzyme can effectively modify steroids and is promising for commercial use.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

DGAT1 enzyme is crucial for healthy skin and hair by regulating retinoid levels.

A specific enzyme that activates the hair growth medication minoxidil when applied to the skin was identified.

The composition helps treat hair loss.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

Inhibiting certain enzymes made female rats more sensitive to low-level pain.